[Mid-term multi-center outcomes of bilateral radial artery as conduits in coronary artery bypass grafting]

X J Chen1, B S Zheng2, Y Zhang3

  • 1Department of Cardiac Surgery, Wuhan First Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Zhonghua Yi Xue Za Zhi
|April 15, 2019
PubMed

Insights

Bilateral radial artery (BRA) grafts are safe and effective for coronary artery bypass grafting (CABG), showing excellent mid-term patency and survival rates. This study highlights BRA as a viable option for total arterial revascularization in CABG patients.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Grafting
  • Cardiac Surgery Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a standard treatment for severe coronary artery disease.
  • The use of arterial grafts, such as bilateral radial artery (BRA) grafts, is increasingly explored for improved long-term outcomes.
  • Evaluating the mid-term efficacy and safety of BRA grafts in CABG is crucial for clinical practice.

Purpose of the Study:

  • To assess the mid-term clinical outcomes of patients undergoing CABG using bilateral radial artery (BRA) grafts.
  • To evaluate the safety, graft patency, and survival rates associated with BRA grafts in a multi-center cohort.
  • To determine the feasibility of BRA grafts for achieving total arterial revascularization in CABG.

Main Methods:

  • Retrospective analysis of perioperative and follow-up data from 211 patients who received BRA grafts for CABG across multiple centers in China.
  • Data collection included patient demographics, disease severity, comorbidities, surgical procedures, complications, and graft patency via coronary CT angiography (CTA).
  • Follow-up duration ranged from 3 to 59 months, assessing clinical events, survival rates, and changes in left ventricular ejection fraction.

Main Results:

  • No operation-related deaths occurred; the cumulative survival rate was 100% at 1 year and 99.53% at 3 years.
  • Coronary CT angiography showed all grafts were patent in 132 patients at a mean follow-up of 21.5 months.
  • Left ventricular ejection fraction significantly improved post-operation (47.1% to 61.0%, P=0.017), with low rates of major complications.

Conclusions:

  • Bilateral radial artery (BRA) grafts are a safe arterial conduit for CABG.
  • BRA grafts facilitate total arterial revascularization and demonstrate favorable mid-term clinical results.
  • The study supports the use of BRA grafts for improved patient outcomes in CABG surgery.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Arteries and Arterioles01:16

Arteries and Arterioles

Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles...
6.5K